A combination pharmaceutical composition and methods of treating diabetes and metabolic disorders

摘要

Disclosed is a pharmaceutical composition for administration to a patient suffering from diabetes and other metabolic disorders, the composition comprises a) a homeopathic activated-potentiated form of an antibody to human insulin receptor, and b) a homeopathic activated-potentiated form of an antibody to endothelial NO-synthase.